Neogenomics (NEO) EPS (Weighted Average and Diluted) Growth (3y) (2014 - 2026)
Neogenomics (NEO) EPS (Weighted Average and Diluted) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -33.24% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 10.09% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -4.22% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 10.81% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 5.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 21.28% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.71% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 251.69% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -0.55% |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | 19.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.59% |
| Dec 31, 2025 | 27.01% |
| Sep 30, 2025 | 11.21% |
| Jun 30, 2025 | -7.72% |
| Mar 31, 2025 | 20.63% |
| Dec 31, 2024 | 30.01% |
| Sep 30, 2024 | 6.27% |
| Jun 30, 2024 | -31.12% |
| Mar 31, 2024 | -3.39% |
| Dec 31, 2023 | -40.71% |
| Sep 30, 2023 | -79.15% |
| Jun 30, 2023 | -46.85% |
| Mar 31, 2023 | -52.86% |
| Dec 31, 2022 | -71.00% |
| Sep 30, 2022 | -157.13% |
| Jun 30, 2022 | -151.98% |
| Mar 31, 2022 | -137.13% |
| Dec 31, 2021 | -352.72% |
| Sep 30, 2021 | -118.98% |
| Jun 30, 2021 | 103.51% |